Finance

Beta
Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
IDR 250.00
+0.81%
(+2.00) 1D
Jul 17, 4:02:50 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
IDR 254
High
IDR 254
Low
IDR 246
Mkt. cap
170.09B
Avg. vol.
543.58K
Volume
55.20K
Dividend
3.02%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
7.96
52-wk high
IDR 555
52-wk low
IDR 190
EPS
IDR 31
Shares outstanding
680.38M
No. of employees
19
Open
IDR 254
High
IDR 254
Low
IDR 246
Mkt. cap
170.09B
Avg. vol.
543.58K
Volume
55.20K
Dividend
3.02%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
7.96
52-wk high
IDR 555
52-wk low
IDR 190
EPS
IDR 31
Shares outstanding
680.38M
No. of employees
19
News stories
From sources across the web
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees19
Founded2015
Headquarters-
SectorPersonal care products
Websitebrigit.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
47.55B
38.18B
45.37B
43.82B
Cost of goods sold
28.35B
18.76B
35.71B
28.17B
Cost of revenue
28.35B
18.76B
35.71B
28.17B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.79B
7.92B
6.42B
10.53B
Operating expense
7.03B
8.67B
7.08B
10.83B
Total operating expenses
35.37B
27.43B
42.80B
39.00B
Operating income
12.18B
10.75B
2.57B
4.83B
Other non operating income
12.09M
-54.54M
165.04M
242.73M
EBT including unusual items
11.81B
10.67B
3.27B
4.87B
EBT excluding unusual items
11.81B
10.69B
3.25B
4.87B
Income tax expense
-
4.46B
2.80B
-
Effective tax rate
-
41.86%
85.71%
-
Other operating expenses
-760.57M
751.69M
660.16M
296.55M
Net income
11.09B
2.38B
2.47B
2.92B
Net profit margin
23.31%
6.22%
5.44%
6.65%
Earnings per share
-
-
-
-
Interest and investment income
-
149.39M
1.36B
72.42M
Interest expense
-199.01M
-156.33M
-1.34B
-266.58M
Net interest expenses
-199.01M
-6.94M
19.56M
-194.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
12.89B
11.71B
2.63B
5.73B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer